Movers and Shakers driving market Buzz

 Top.Gainers
 
  Top.Gainers
 
Follow  Message
 
 
 
Top.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
 

•  05 Mar 2026
 

•   CDTG  
   
  +18.42%
•   IBO  
   
  +6.67%
•   MVIS  
   
  +1.85%
•   SOC  
   
  +3.51%
•   TNGX  
   
  +1.20%

$IBO Impact Biomedical is stealing the spotlight after an explosive after-hours surge tied to a regulatory filing update that sparked speculative momentum. Shares jumped more than 55% during the session with extraordinary trading activity exceeding 200 million shares. When a micro-cap name suddenly attracts that level of liquidity, it often signals a mix of retail enthusiasm and short-term momentum traders piling in. The move suggests traders are reacting to the potential implications of the SEC filing amendments, but sustainability will likely depend on whether follow-up disclosures provide tangible operational progress.

$CDTG CDT Environmental Technology also caught traders’ attention after a powerful after-hours pop following a strong regular session rally. The stock surged over 40% while volume reached nearly nine times its average, a clear signal that the move was not random noise. Speculation around environmental technology demand and the positioning in the sustainability sector appears to be fueling sentiment. In thinly traded small caps, when volume expands this dramatically it often indicates momentum-driven flows rather than fundamental repricing, but those flows can carry a stock much farther than expected in the short term.

$SOC continued its impressive run, extending a five-day winning streak and climbing more than 37% as traders chased the momentum. The move came with nearly 18 million shares traded compared with an average of about six million, showing a significant increase in market participation. When a stock strings together multiple strong sessions like this, it typically reflects a combination of positive sentiment, technical breakouts, and algorithmic momentum strategies stepping in. Traders now appear focused on whether the rally can sustain above recent resistance levels as the trend gains broader visibility.

$TNGX Tango Therapeutics surged after reporting its fourth-quarter and full-year 2025 results alongside updates from its Phase 1/2 clinical program involving vopimetostat in combination with RAS-targeting therapies for MTAP-deleted pancreatic cancer. Biotechnology names often react sharply to clinical progress, and the market seems to be pricing in the potential significance of early-stage data tied to difficult-to-treat cancers. The stock gained more than 36% with volume running far above normal levels, suggesting the update resonated with both biotech specialists and momentum traders looking for catalyst-driven moves.

$MVIS MicroVision found itself on the opposite side of the leaderboard as shares dropped more than 29% following its latest earnings call and updated outlook. Despite outlining a strategic shift toward LiDAR 2.0 and a push into defense applications, the revenue expectations for the coming years appear to have disappointed investors. Heavy trading volume approaching 40 million shares signals that the selloff was driven by broad repositioning rather than light profit-taking. When sentiment turns this sharply in speculative technology names, the market often demands clearer evidence of revenue traction before confidence returns.

View All Headlines